After Y90-RE therapy, the within MC group demonstrated a lower incidence of ascites (12% vs. 26%; p = 0.03), lower levels of alkaline phosphatase (124 ± 58 U/L vs. 161 ± 114; p = 0.02), and higher levels of albumin (3.6 ± 0.5 g/dL vs. 3.3 ± 0.6 g/dL; p = 0.004) than the outside MC group. This evidence concerns the gene ALB and Ascites.